![Jan Magnus Lundberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan Magnus Lundberg
Direttore/Membro del Consiglio presso Ferring Holding SA
Provenienza dei contatti di primo grado di Jan Magnus Lundberg
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Ferring Holding SA
![]() Ferring Holding SA Pharmaceuticals: MajorHealth Technology Ferring Holding SA operates as a holding company with interests in pharmaceutical products. The company was founded in 2000 and is headquartered in Saint-Prex, Switzerland.
3
| Private Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jan Magnus Lundberg tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Ferring International Center SA
![]() Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Ferring Pharmaceuticals A/S
![]() Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member | |
ACINO HOLDING AG | Pharmaceuticals: Major | Chairman | |
University of St. Gallen | College/University | Masters Business Admin | |
Solvias AG
![]() Solvias AG BiotechnologyHealth Technology Solvias AG engages in contract research, development, and manufacturing. It offers analytical, small molecule, biopharmaceutical, solid state development, catalysis technology, custom synthesis and manufacturing, and biological analysis services. The firm serves the pharmaceutical, biotech, medical devices, cosmetics, agro chemical, chemical, eletronic materials, and life sciences industries. The company was founded in 1999 and is headquartered in Kaiseraugst, Switzerland. | Biotechnology | Chairman | |
EyeSense AG
![]() EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | Medical Specialties | Chairman | |
Novartis Ophthalmics AG | Chief Executive Officer | ||
Ixodes AG
![]() Ixodes AG Pharmaceuticals: MajorHealth Technology Ixodes AG develops, produces and markets pharmaceutical products. It operates as a pharmaceutical company that improves patient lives through technologies for the prevention of Lyme disease. The firm's product Ixogel, is a solution to prevent Lyme disease via a topical application of an antibiotic after a tick bite. The company was founded in 2007 and is headquartered in Zumikon, Switzerland. | Pharmaceuticals: Major | Director of Finance/CFO | |
Sequana Medical AG
![]() Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Medical Specialties | Chairman | |
Ferring Pharmaceuticals SA
![]() Ferring Pharmaceuticals SA BiotechnologyHealth Technology Ferring Pharmaceuticals SA develops and markets biopharmaceutical products. It provides products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. The company was founded by Frederik Paulsen Sr in 1950 and is headquartered in Saint-Prex, Switzerland. | Biotechnology | Director/Board Member | |
Oculocare AG | Miscellaneous | Director/Board Member | |
Ferring Pharmaceuticals Ltd.
![]() Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Orasis Pharmaceuticals Ltd.
![]() Orasis Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Orasis Pharmaceuticals Ltd. operates as a clinical stage pharmaceutical company. It develops eye drops for the treatment of presbyopia as an alternative to reading glasses. The company was founded in 2015 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Nicox Ophthalmics, Inc.
![]() Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Pharmaceuticals: Major | Director/Board Member | |
FinVector Oy
![]() FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Pharmaceuticals: Major | Chairman | |
NICOX SA | Pharmaceuticals: Major | Director/Board Member | |
Essity Germany GmbH
![]() Essity Germany GmbH Household/Personal CareConsumer Non-Durables Part of Industrivärden AB, Essity Germany GmbH is the world's second largest supplier of consumer tissue, offering a range of products including toilet paper, kitchen rolls, facial tissues, handkerchiefs, and napkins. Essity Germany is based in Mannheim, DE, and Andreas Pier has been the CEO of the company since 2018. The German company provides practical advice for maintaining a clean and cozy home. | Household/Personal Care | Director/Board Member | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Bertelsmann Management SE
![]() Bertelsmann Management SE Miscellaneous Commercial ServicesCommercial Services Bertelsmann Management SE is an international media enterprise with corporate divisions including RTL Group, Penguin Random House, and Gruner + Jahr. The private company is based in Gütersloh, DE and has a global presence of subsidiaries in several regions. The German company's Press Center provides detailed information for journalists, and the company is also committed to Corporate Responsibility activities. Thomas Hermann Rabe has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
University of Copenhagen | College/University | Graduate Degree | |
Copenhagen Business School | College/University | Undergraduate Degree | |
ORSTED A/S | Electric Utilities | Director/Board Member | |
BERTELSMANN SE & CO. KGAA | Movies/Entertainment | Director/Board Member | |
Danmarks Nationalbank | Major Banks | Director/Board Member | |
THERMO FISHER SCIENTIFIC | Medical Specialties | Director/Board Member | |
CARLSBERG A/S | Beverages: Alcoholic | Director/Board Member | |
Novo Holdings A/S (Investment Company)
![]() Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chairman | |
Carlsberg Breweries A/S
![]() Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Beverages: Alcoholic | Chairman | |
Novo Nordisk Fonden
![]() Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman | |
SVENSKA CELLULOSA AKTIEBOLAGET SCA | Pulp & Paper | Director/Board Member | |
Novo Holdings AS (Denmark)
![]() Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chairman | |
ESSITY AB | Household/Personal Care | Director/Board Member | |
London School of Economics & Political Science | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
Svizzera | 13 |
Danimarca | 13 |
Stati Uniti | 4 |
Germania | 4 |
Regno Unito | 3 |
Settori
Health Technology | 18 |
Consumer Services | 6 |
Consumer Non-Durables | 6 |
Finance | 5 |
Miscellaneous | 3 |
Posizioni
Director/Board Member | 27 |
Chairman | 14 |
Independent Dir/Board Member | 6 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 3 |
Contatti più connessi
- Borsa valori
- Insiders
- Jan Magnus Lundberg
- Connessioni Società